"Immunogenicity of Hepatitis B Vaccines Among Infant Recipients of Acellular and Whole Cell Pertussis DTP Vaccines."

According to the authors' abstract of an article published in Vaccine, "The study was conducted to assess the immunogenicity of three doses of two recombinant hepatitis B virus (HBV) vaccines, administered simultaneously with a DT vaccine or one of three different pertussis vaccines combined with diphtheria and tetanus toxoids. The study population consisted of 1,237 children selected from the cohort of 15,601 children enrolled in the Italian trial on pertussis vaccines. HBV vaccination was performed at 2, 4, and 12 months of age, with the first two doses concurrent with OPV and DTP vaccination. The DTP vaccines administered in the pertussis trial included one whole cell DTP, licensed...

Want to see the full article?

• Purchase this article for only $3.00